11.2.2 May 04, 2017: ConvaTec Group: Trading Update for the three months ended 31 March 2017 186
11.2.3 May 03, 2017: Coloplast delivers satisfactory Q2 result 187
11.2.4 Mar 01, 2017: Product launch of 4D Lifetest at the 56th Annual Meeting of the Society of Toxicology 188
11.2.5 Feb 28, 2017: Endo Reports Fourth-Quarter And Full-Year 2016 Financial Results 189
11.2.6 Feb 02, 2017: Coloplast delivers Satisfactory Q1 Interim Results in Line with Guidance 191
11.2.7 Nov 08, 2016: Endo Reports Third Quarter 2016 Financial Results 192
11.2.8 Nov 02, 2016: Coloplast delivers full-year results in line with guidance 193
11.2.9 Oct 17, 2016: Shire Announces Update to Vyvanse (lisdexamfetamine dimesylate) U.S. Labeling to Include New Longer-Term Maintenance of Efficacy Data in Adults with Moderate to Severe Binge Eating Disorder 194
11.2.10 Aug 16, 2016: Coloplast delivers 9M result in line with guidance 196
11.2.11 Aug 08, 2016: Endo Reports Second Quarter 2016 Financial Results 196
11.3 Legal And Regulatory 198
11.3.1 Jun 07, 2017: Endo Announces Entry of Significant Case Management Order in Mesh Multidistrict Litigation 198
11.4 Other Significant Developments 199
11.4.1 Jan 26, 2017: Endo Announces Actions to Drive Greater Efficiency and Business Alignment 199
11.5 Product News 199
11.5.1 Apr 24, 2017: Proxy Biomedical Group Announces New Corporate Brand Aran Biomedical 199
11.6 Strategy And Business Planning 200
11.6.1 Jul 21, 2017: Endo to Restructure Manufacturing Network 200
GlobalData’s new report, EU5 Incontinence Devices Market Outlook to 2023, provides key market data on the EU5 Incontinence Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Protective Garments for Incontinence, Urinary Catheters and Urine Bags.
The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Market size and company share data for Incontinence Devices market segments - Protective Garments for Incontinence, Urinary Catheters and Urine Bags.
Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
2016 company shares and distribution shares data for each of the market segments.
Global corporate-level profiles of key companies operating within the EU5 Incontinence Devices market.
Key players covered include Kimberly-Clark Corporation, Cardinal Health Inc, First Quality Enterprises Inc, Svenska Cellulosa Aktiebolaget and Medtronic plc.
Reasons to buy
Develop business strategies by identifying the key market segments poised for strong growth in the future.
Develop market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.